Details for Patent: 12,679,836
Which drugs does patent 12,679,836 protect, and when does it expire?
Patent 12,679,836 protects HYRNUO and is included in one NDA.
This patent has forty patent family members in thirty-four countries.
Summary for Patent: 12,679,836
| Title: | 4H-pyrrolo[3,2-c]pyridin-4-one compounds |
| Abstract: | Compounds of formula (I), formula (I), processes for their production and their use as pharmaceuticals. |
| Inventor(s): | Stephan Siegel, Franziska SIEGEL, Volker Schulze, Markus Berger, Keith Graham, Detlev Sülzle, Ulf Bömer, Daniel Korr, Jens Schröder, Ursula Mönning, Michael Niehues, Matthew Meyerson, Heidi Greulich, Bethany Kaplan |
| Assignee: | Bayer AG , Dana Farber Cancer Institute Inc , Broad Institute |
| Application Number: | US17/605,975 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 12,679,836
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare | HYRNUO | sevabertinib | TABLET;ORAL | 219972-001 | Nov 19, 2025 | RX | Yes | Yes | 12,679,836 | ⤷ Start Trial | Y | Y | TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) WHOSE TUMORS HAVE HER2 (ERBB2) TYROSINE KINASE DOMAIN (TKD) ACTIVATING MUTATIONS AND WHO HAVE RECEIVED A PRIOR SYSTEMIC THERAPY | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,679,836
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 118748 | ⤷ Start Trial | |||
| Australia | 2020262221 | ⤷ Start Trial | |||
| Brazil | 112021019998 | ⤷ Start Trial | |||
| Canada | 3137218 | ⤷ Start Trial | |||
| Chile | 2021002770 | ⤷ Start Trial | |||
| China | 114127064 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
